{"result": "(\"entity\"<|>MEN1<|>EVENT<|>MEN1 is a syndrome characterized by the presence of multiple endocrine tumors, including those of the parathyroid glands, pancreatic endocrine cells, and pituitary cells.)\n##\n(\"entity\"<|>MEN2<|>EVENT<|>MEN2 is another syndrome that involves multiple endocrine neoplasia, but with different tumor associations compared to MEN1.)\n##\n(\"entity\"<|>D.<|>PERSON<|>D. is a medical professional involved in the diagnosis and treatment of patients with endocrine disorders.)\n##\n(\"entity\"<|>SPAIN<|>GEO<|>Spain is the country where the patient was referred for medical evaluation and treatment.)\n##\n(\"entity\"<|>HYPERCALCEMIA<|>EVENT<|>Hypercalcemia is a condition characterized by an elevated level of calcium in the blood, which is relevant in the context of endocrine tumors.)\n##\n(\"entity\"<|>PRL<|>EVENT<|>Prolactin (PRL) is a hormone that can indicate the presence of certain types of tumors, particularly in the context of pituitary adenomas.)\n##\n(\"entity\"<|>TUMOR<|>EVENT<|>A tumor is an abnormal growth of tissue, which can be benign or malignant, and is a central focus in the patient's medical history.)\n##\n(\"relationship\"<|>D.<|>MEN1<|>D. is involved in the clinical diagnosis and management of patients with MEN1 syndrome<|>8)\n##\n(\"relationship\"<|>D.<|>MEN2<|>D. is involved in the clinical diagnosis and management of patients with MEN2 syndrome<|>8)\n##\n(\"relationship\"<|>SPAIN<|>D.<|>D. is practicing medicine in Spain, where the patient was referred<|>7)\n##\n(\"relationship\"<|>HYPERCALCEMIA<|>MEN1<|>Hypercalcemia is a common finding in patients with MEN1 syndrome<|>6)\n##\n(\"relationship\"<|>PRL<|>MEN1<|>Elevated PRL levels are often associated with pituitary adenomas in MEN1 syndrome<|>6)\n##\n(\"relationship\"<|>TUMOR<|>MEN1<|>The presence of tumors is a key characteristic of MEN1 syndrome<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: estudio genético de mutaciones del gen MEN1.\nD. Es probable que tenga o que desarrolle en el seguimiento un tumor neuroendocrino gastroenteropancreático.\n---\nMETABOLISMO FOSFOCÁLCICO, TUMORES\nNEUROENDOCRINOS Y MEN\n\n## 41. Una paciente de 27 años consulta con su médico de atención primaria por amenorrea de 4 meses. En la analítica realizada se aprecia una PRL de 390 ng/ml por lo que nos la remite a consulta. Cuando la vemos por primera vez es difícil historiarla porque viene de otro país y apenas habla nuestro idioma. Conseguimos entender que hace 2 años fue intervenida en su país de un tumor en páncreas diagnosticado incidentalmente. Aunque no tenemos ningún informe, por la edad y evolución sospechamos que era un tumor neuroendocrino. No tuvo nunca ninguna clínica que haga pensar que el tumor fuese funcionante: específicamente no hipoglucemias, no úlceras pépticas, no diarrea, etc. No puede proporcionarnos antecedentes familiares porque sus padres murieron siendo ella muy joven. En la exploración física no hay nada reseñable salvo galactorrea bilateral a expresión por varios conductos galactóforos. En la analítica vemos un calcio de 11,1 mg/dl (8,5-10,4 mg/dl). Revisando la historia, ya se detectaba hipercalcemia en la primera analítica que le habían hecho al llegar a España (Ca 10,8 mg/dl). Señale la respuesta cierta acerca de esta paciente:\n\nA. Tomando los datos en conjunto sugiere que debemos descartar un MEN2.\nB. Es importante tener en mente que podemos estar ante un MEN1, por lo que habría que pedir un estudio genético del protooncogén RET.\nC. No puede ser un MEN porque el tumor en páncreas era no funcionante y en este cuadro los tumores neuroendocrinos son siempre funcionantes (sobre todo gastrinomas e insulinomas).\nD. Si se detecta un macroadenoma hipofisario productor de PRL, la actitud terapéutica es la misma, tanto si es un MEN como si no lo es.\n\n### COMENTARIO\n\nEl diagnóstico clínico de síndrome de MEN1 se realiza en un paciente que presenta dos tumores clásicamente asociados a este síndrome: de las células paratiroides (90-100%), de las células endocrinas pancreatoduodenales (30-70%) y/o de las células hipofisarias (10-65%). Ante este diagnóstico existe indicación de realizar el estudio del gen MEN1 para confirmar el diagnóstico y poder estudiar a los familiares.\n\nEl adenoma secretor de PRL es el más común de los tumores hipofisarios en MEN1. En la serie franco-belga publicada en 2002, los pacientes con MEN1 tenían tres veces más probabilidades de tener un macroadenoma que un microadenoma hipofisario, aunque recientemente los datos de la serie neerlandesa no corroboraron estos hallazgos quizás porque más pacientes fueron diagnosticados tras cribado genético.\n\nLos síntomas clínicos y el tratamiento es igual que en los casos esporádicos, aunque se ha descrito que suelen ser más resistentes al tratamiento médico y tienen mayor tendencia a recurrir tras la cirugía, aunque nuevamente la serie neerlandesa no confirma estos datos.\n\nEn esta paciente se debería haber sospechado el síndrome de MEN1 ante la persistencia del HPP tras la cirugía, unido a la presencia de dos adenomas y a la edad de diagnóstico inferior a 50 años. Se tendría que haber realizado el estudio genético o al menos un cribado bioquímico/radiológico de los tumores más frecuentes asociados a este síndrome, como son los TNE pancreáticos no funcionantes, gastrinomas y prolactinomas.\n\nEl nivel de PRL > 500 ng/dl es sugestivo de macroprolactinoma, así como el hecho de presentar también déficit de otros ejes hipofisarios.\n\nEl carcinoma medular de tiroides no se ha descrito entre los múltiples tumores asociados a MEN1.\n\nReferencias:\n- Melmed S, Polonsky KS, Reed Larsen P, Kronenberg HM. Williams Textbook of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016.\n- Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1). J Clin Endocrinol Metab. 2012;97:1-22.\n- Valdés Gallego N. Manual de Endocrinología y Nutrición (Internet). Capítulo 3. Neoplasia Endocrina Múltiple. Madrid: Sociedad Española de Endocrinología y Nutrición; 2015. Disponible en: https://manual.seen.es.\n\n## Casos clínicos. Caso clínico 1\n\n### 42. En\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}